Abstract
We present two cases of patients with severe persistent diarrhoea, in whom duodenal biopsies revealed villous atrophy that could be attributed to the use of olmesartan. The differential diagnosis of villous atrophy without serological markers of celiac disease should include drugs as possible cause, with olmesartan as a recently discovered culprit. Gastroenterologist should be aware of this entity.
Keywords:
coeliac disease; diarrhea; olmesartan.
© Acta Gastro-Enterologica Belgica.
MeSH terms
-
Aged
-
Angiotensin II Type 1 Receptor Blockers / administration & dosage
-
Angiotensin II Type 1 Receptor Blockers / adverse effects
-
Atrophy / chemically induced
-
Atrophy / pathology
-
Biopsy / methods
-
Diagnosis, Differential
-
Diarrhea* / diagnosis
-
Diarrhea* / etiology
-
Diarrhea* / physiopathology
-
Diarrhea* / therapy
-
Duodenum / pathology*
-
Female
-
Humans
-
Imidazoles / administration & dosage
-
Imidazoles / adverse effects*
-
Intestinal Mucosa* / ultrastructure
-
Male
-
Microvilli / pathology*
-
Tetrazoles / administration & dosage
-
Tetrazoles / adverse effects*
-
Treatment Outcome
-
Withholding Treatment
Substances
-
Angiotensin II Type 1 Receptor Blockers
-
Imidazoles
-
Tetrazoles
-
olmesartan